Using innovative
biochip technology,
we make multiplex test
simple and more reliable.
Genesystem is proud to commercialize multiplex testing chip format
which is intended for detecting multiple targets up to 10 from single
sample. Genesystem also owns the technology enabling high multiplex
detections up to 50 targets which is ideal for syndromic disease
diagnostics panel. Please consult Genesystem to integrate your multiplex
assay panel to this innovative molecular testing format.
Set up your own
food testing lab
with our compact
and affordable solution.
Genesystem offers food safety testing assays optimized for its
GENECHECKER qPCR platform. This assay is being AOAC certified to
meet the needs in global market. Genesystem also offers porcine
detection assay for Halal assurance testing and meat species
identification kits for food fraud surveillance and raw material inspections
in food industry.
GENECHECKER®
qPCR Platforms
for Point-of-Care
Molecular Testing
Using state-of-the-art hardware technology fused with innovative
biochip designing and manufacturing technology, ultra-fast PCR can
be made with GENECHECKER platforms. Small footprint, light weight
and make the system ideal for point-of-care testing applications.
With its uniquely
featured molecular
testing platforms,
Genesystem is endeavoring to
contribute to human health.
Genesystem has been running a high standard of GMP facility for securing innovative production technology and
stable quality management system. On the basis of reliable production and quality control system, Genesystem is
successfully implementing its business model of supplying diagnostic system and diagnostic assays to global market.
About Genesystem
Genesystem is a biotech engineering company in South Korea specializing in molecular testing platforms to target on-site testing needs. Adding to marketing its standard products in global market, Genesystem has been successfully running partnerships with molecular testing assay manufacturers.
Learn more+Pipeline
Genesystem is implementing its research and development activities on the basis of clear roadmap to become the global leader in multiplex point-of-care diagnostics market.
Learn more+